Clinical Trials at Northwest Medical Specialties, PLLC
As of August 2026, 13 paid clinical trials are recruiting at Northwest Medical Specialties, PLLC, located at 1624 S I ST, SUITE 305, TACOMA, WA 98405-5016, phone (253) 428-8700 in Tacoma, Washington. Active studies at this site cover conditions such as Crohn's Disease, Multiple Myeloma and Ulcerative Colitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at Northwest Medical Specialties, PLLC
·Clear filters·This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
SLV-154 Treatment of Advanced Cancers
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Common conditions studied in Tacoma
- Crohn's Disease (8 active studies)
- Multiple Myeloma (7 active studies)
- Ulcerative Colitis (7 active studies)
- Colitis, Ulcerative (6 active studies)
- Breast Cancer (5 active studies)
- Breast Neoplasms (5 active studies)
Leading research sponsors in Tacoma
- Children's Oncology Group
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Tacoma?
There are approximately 151 recruiting clinical trials in Tacoma, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tacoma pay participants?
Most recruiting trials in Tacoma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tacoma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tacoma?
The most common conditions under active study in Tacoma include Crohn's Disease (8), Multiple Myeloma (7), Ulcerative Colitis (7), Colitis, Ulcerative (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tacoma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tacoma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tacoma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tacoma?
Recruiting research sites in Tacoma include Mary Bridge Children's Hospital and Health Center, Madigan Army Medical Center, Northwest Medical Specialties, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tacoma right now?
The largest active categories in Tacoma are Cancer & tumors (68), Diabetes & metabolic (10), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Northwest Medical Specialties, PLLC?
Northwest Medical Specialties, PLLC is located at 1624 S I ST, SUITE 305, TACOMA, WA 98405-5016. Use the Google Maps link in the intro above to get directions.
How do I contact Northwest Medical Specialties, PLLC?
You can reach Northwest Medical Specialties, PLLC by phone at (253) 428-8700. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.